DNASense has rapidly advanced technologically and experienced significant growth in recent years. Joining Clinical Microbiomics, a leading microbiome CRO in North America and Europe, marks another major milestone in our development, furthering our mission to enable pioneering microbiome science across a wide array of human, animal, and environmental applications.
Benefiting from the challenging projects received from customers and collaborators, DNASense has thrived as a cutting-edge startup. As part of Clinical Microbiomics, we aim to enhance our services for all stakeholders further. 🌟
Also, looking even further ahead, we are thrilled to announce unveiling a new parent company brand in the summer of 2024, reflecting the shared vision of Clinical Microbiomics and DNASense and advancing the microbiome revolution. 🧬🦠
Read more at: clinical-microbiomics.com/dnasense/